68 Recruiting Glioblastoma Multiforme Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Glioblastoma Multiforme
Related Conditions
Top Recruiting Glioblastoma Multiforme Studies
A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme
📍 Holden Comprehensive Cancer Center — Iowa City, Iowa
View Study & Checklist ➔Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)
📍 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
View Study & Checklist ➔Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme
📍 Sibley Memorial Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM
📍 Center for Neurosciences — Tucson, Arizona
View Study & Checklist ➔Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients
📍 Barrow Brain and Spine — Phoenix, Arizona
View Study & Checklist ➔Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
📍 Stanford University — Stanford, California
View Study & Checklist ➔Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM
📍 Duke University Medical Center — Durham, North Carolina
View Study & Checklist ➔A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)
📍 Research Site — Los Angeles, California
View Study & Checklist ➔Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
📍 University of Southern California — Los Angeles, California
View Study & Checklist ➔Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM
📍 Montreal Neurological Institute - McGill University Health Centre — Montreal, Quebec
View Study & Checklist ➔A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)
📍 University of California, Los Angeles — Los Angeles, California
View Study & Checklist ➔Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients
📍 AdventHealth Translational Research Institute — Orlando, Florida
View Study & Checklist ➔NG101m Adjuvant Therapy in Glioblastoma Patients
📍 Yvonne Kew MD, PLLC — Houston, Texas
View Study & Checklist ➔A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research
📍 Power Life Sciences — San Francisco, California
View Study & Checklist ➔Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
📍 Lenox Hill Brain Tumor Center — New York, New York
View Study & Checklist ➔Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
📍 University of California at Los Angeles — Los Angeles, California
View Study & Checklist ➔HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
📍 Houston Methodist Neurological Institute — Houston, Texas
View Study & Checklist ➔Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
📍 Johns Hopkins Medical Institution — Baltimore, Maryland
View Study & Checklist ➔Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma
📍 CHUS — Sherbrooke, Quebec
View Study & Checklist ➔Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
📍 Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
View Study & Checklist ➔Tamoxifen Versus Etoposide After First Recurrence in GBM Patients
📍 Cross Cancer Institute — Edmonton, Alberta
View Study & Checklist ➔Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients
📍 Arthur J.E. Child Comprehensive Cancer Center (formerly Tom Baker Cancer Centre) — Calgary, Alberta
View Study & Checklist ➔A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
📍 University of Virginia — Charlottesville, Virginia
View Study & Checklist ➔IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma
📍 University of Florida Health — Gainesville, Florida
View Study & Checklist ➔Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Study of Pembrolizumab and M032 (NSC 733972)
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)
📍 University Hospitals Cleveland Medical Center — Cleveland, Ohio
View Study & Checklist ➔Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme
📍 Stony Brook University Hospital — Stony Brook, New York
View Study & Checklist ➔IA Carboplatin + Radiotherapy in Relapsing GBM
📍 CHUS — Sherbrooke, Quebec
View Study & Checklist ➔Loupe-Based Intraoperative Fluorescence Imaging
📍 University of Kentucky — Lexington, Kentucky
View Study & Checklist ➔Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
📍 Jackson Memorial Hospital — Miami, Florida
View Study & Checklist ➔A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
📍 University of Alabama Birmingham — Birmingham, Alabama
View Study & Checklist ➔